Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Geriatrics & Gerontology International|September 27, 2014
Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter studySerdal Korkmaz, Mehmet Sinan Dal, Ilhami Berber, et al.Bone Marrow Transplantation|October 28, 2020
COVID-19 in hematopoietic cell transplant recipientsFevzi Altuntas, Naim Ata, Tugce Nur Yigenoglu, et al.Journal of Chemotherapy (Florence, Italy)|May 22, 2023
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in TurkeyMehmet Bakırtaş, Mehmet Sinan Dal, Tuğçe Nur Yiğenoğlu, et al.Clinical Lymphoma, Myeloma & Leukemia|June 1, 2021
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid LeukemiaAliihsan Gemici, Fahir Ozkalemkas, Mehmet Hilmi Dogu, et al.Hematological Oncology|July 15, 2017
Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experienceAliihsan Gemici, Ismet Aydogdu, Hatice Terzi, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2021
Pralatrexate experience in PTCL: A multicenter retrospective study from TurkeyMehmet Sinan Dal, Alparslan Merdin, Mehmet Ali Erkurt, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 4, 2020
Convalescent plasma therapy in patients with COVID-19Fevzi Altuntas, Naim Ata, Tugce Nur Yigenoglu, et al.Annals of Hematology|May 14, 2021
Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experienceDeniz Goren Sahin, Olga Meltem Akay, Muzaffer Keklik, et al.Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and SafetyMehmet Bakirtas, Ipek Yonal Hindilerden, Bahar Uncu Ulu, et al.Clinical Lymphoma, Myeloma & Leukemia|October 11, 2021
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLLSeval Akpinar, Mehmet Hilmi Dogu, Serhat Celik, et al.Pageof 4